Current Neuropharmacology
Title:Editorial: Recent Advances in Pathophysiological Studies and Treatment of Epilepsy
Volume: 16 Issue: 1
Author(s): Guanghao Yin, Gang Yao, Kun Zhang and Bingjin Li*
Affiliation:
- Jilin Provincial Key Laboratory on Molecular and Chemical Genetic, the Second Hospital of Jilin University, 218 Ziqiang Street, Changchun 130041,China
Export Options
About this article
Cite this article as:
Yin Guanghao , Yao Gang , Zhang Kun and Li Bingjin *, Editorial: Recent Advances in Pathophysiological Studies and Treatment of Epilepsy, Current Neuropharmacology 2018; 16 (1) . https://dx.doi.org/10.2174/1570159X1601171214093823
DOI https://dx.doi.org/10.2174/1570159X1601171214093823 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
27
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Obituary
Mini-Reviews in Medicinal Chemistry A Review on Pharmacokinetics of Levetiracetam in Neonates
Current Drug Metabolism A Magnetic Resonance Spectroscopy Study of Lovastatin for Treating Bipolar Mood Disorder: A 4-Week Randomized Double-Blind, Placebo- Controlled Clinical Trial
Recent Patents on Inflammation & Allergy Drug Discovery Pyrazolo-Triazolo-Pyrimidine Derivatives as Adenosine Receptor Antagonists: A Possible Template for Adenosine Receptor Subtypes?
Current Pharmaceutical Design Natural Plants with Antiepileptic Activity-The Present and Future Perspectives
The Natural Products Journal Editorial
Recent Patents on CNS Drug Discovery (Discontinued) Functional Genomics- and Network-driven Systems Biology Approaches for Pharmacogenomics and Toxicogenomics
Current Drug Metabolism Preface
Current Pharmaceutical Design Relationship Between Susceptibility to DMCM-Induced Generalized Motor Convulsions and Low-Affinity [3H]-Ouabain Binding in Membranes in Rat Brain
Current Molecular Pharmacology Integration of Pharmacogenomics and Pharmacometrics to Support Drug Development, Regulatory and Therapeutic Decisions
Current Pharmacogenomics and Personalized Medicine On the Involvement of H2S in Nitroso Signaling and Other Mechanisms of H2S Action
Current Pharmaceutical Biotechnology Relevance of Excitable Media Theory and Retinal Spreading Depression Experiments in Preclinical Pharmacological Research
Current Neuropharmacology Interleukin-4-Induced Oxidative Stress Via Microglial NADPH Oxidase Contributes to the Death of Hippocampal Neurons In Vivo
Current Aging Science Stem Cell Therapy for Ischaemic Stroke: Translation from Preclinical Studies to Clinical Treatment
CNS & Neurological Disorders - Drug Targets Rapid Quantification of Neurons and Stem/Progenitor Cells in the Adult Mouse Brain by Flow Cytometry
Letters in Drug Design & Discovery Pediatric Catatonia: Updating An Old Syndrome in Young People
Current Psychiatry Reviews Pharmacotherapy for SARS-CoV-2 and Seizures for Drug Repurposing Presumed on Mechanistic Targets
Current Molecular Pharmacology Biomarker-Guided Strategy for Treatment of Autism Spectrum Disorder (ASD)
CNS & Neurological Disorders - Drug Targets Patent Selections:
Recent Patents on Biotechnology (Pro)renin Receptor as a New Drug Target
Current Pharmaceutical Design